55
Views
1
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Levetiracetam is as effective as carbamazepine in newly diagnosed epilepsy

&
Pages 599-601 | Published online: 09 Jan 2014

References

  • Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology6, 402–408 (2007).
  • LaRoche SM, Helmers SL. The new antiepileptic drugs: clinical applications. JAMA291(5), 615–620 (2004).
  • Zaccara G, Messori A, Cincotta M, Burchini G. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies? Acta Neurol. Scand.114(3), 157–168 (2006).
  • Bergin AM, Connolley M. New antiepileptic drug therapies. Neurol. Clin.20(4), 1163–1182 (2002).
  • French J, Schatcher S. A workshop on antiepileptic drug monotherapy indications. Epilepsia43(Suppl. 10), 3–27 (2002).
  • French J. Historical control in patients withdrawn to monotherapy. Epilepsy Res.68(1), 74–77 (2006).
  • Schmidt B. Clinical development of antiepileptic drugs in adults. Neurotherapeutic4(1), 62–69 (2007).

Website

  • Off-label and investigational use of marketed drugs, biologics and medical devices http://fda.gov/oc/ohrt/irbs/offlabel.html (Accessed April 2007)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.